How hormone therapy affects your quality of life
Part of Brain & nervous system, Cancer, Mental health, Pain, Skin clinical trials.
This study looks at how hormone therapy affects your quality of life. You'll answer questionnaires about your symptoms and well-being over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with stage I, II, or III breast cancer.
- You are currently taking hormone therapy (like Tamoxifen or an aromatase inhibitor) and started it within the last year.
- You are between 18 and 75 years old.
- You are likely to live for more than 3 months after starting treatment.
- You are able to understand the study and follow its instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a wearable watch and smartphone app to track activity and fitness can help monitor health in people with hormone receptor–positive, HER2-negative metastatic breast cancer while they take standard hormone therapy plus palbociclib. It mainly requires that you are already on these medicines for at least three months and can use the devices reliably.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
This trial tests a lifestyle adjustment program for women who have finished chemotherapy for early-stage breast cancer. It aims to help you make healthy changes and improve your well-being.
This study looks at how breast cancer surgery affects your quality of life. It includes people with any stage of breast cancer (or at high risk) who need breast surgery under general anesthesia. The goal is to learn how to better support your recovery and well-being.
This trial tests if a supervised exercise program can improve quality of life for people with early-stage breast cancer who are currently taking hormone therapy (aromatase inhibitors with or without CDK4/6 inhibitors). It aims to see if exercise helps reduce side effects like fatigue and pain.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.